Does Siponimod Interact with Dual Strong Cyp3a4 Moderate Cyp1a2 Inducers?
Siponimod and Dual Strong Cyp3a4 Moderate Cyp1a2 Inducers have a major drug interaction according to U.S. FDA drug labeling data. Dual moderate CYP2C9/strong CYP3A4 inducers decrease siponimod exposure; concomitant use is not recommended. The mechanism involves cyp2c9/cyp3a4 induction decreases drug exposure. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.
- Severity
- Major
- Siponimod Class
- Sphingosine 1-phosphate Receptor Modulator
- Management
- Close medical supervision required
- Data Source
- U.S. FDA via OpenFDA
How This Interaction Works
The interaction between Siponimod and Dual Strong Cyp3a4 Moderate Cyp1a2 Inducers occurs because cyp2c9/cyp3a4 induction decreases drug exposure. Clinically, this means dual moderate cyp2c9/strong cyp3a4 inducers decrease siponimod exposure; concomitant use is not recommended. This is classified as a major interaction, meaning it could cause serious harm if not properly managed. Your healthcare provider may need to adjust dosages, substitute one medication, or increase monitoring frequency.
What To Tell Your Doctor or Pharmacist
If you are taking Siponimod and your doctor is considering prescribing Dual Strong Cyp3a4 Moderate Cyp1a2 Inducers (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask how frequently you should be monitored while these are co-prescribed
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider